Tectonic Therapeutic, Inc. - TECX Company profit before taxes, interest and amortization
The success of Tectonic Therapeutic, Inc. (TECX) depends on the safety of new proteins and capital inflows, which are effectively coordinated by experienced R&D management. The GURU.Markets system brings the net operating income level up to depreciation, where the current metric equals 0.00, capturing a stable cash flow. This confirms the value of the GEODE platform, which creates a significant scientific barrier for competitors in the field of targeted therapy.
Tectonic Therapeutic - analytical breakdowns and key metrics (TECX)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Tectonic Therapeutic, Inc.|TECX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Tectonic|TECX - Company Aggregate Debts|Debts to Book Value Tectonic Therapeutic, Inc.|TECX - Company Long-Term Debts|Company Current Liabilities Tectonic Therapeutic|Intermediate Liquidity Ratio tectonictx.com
- earnings and market ratios statistics:
TECX - Company Net Income|Expected Net Profit Tectonic Therapeutic, Inc.|TECX - Price to Earnings Ratio|Price to Future Earnings Ratio Tectonic|TECX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Tectonic Therapeutic, Inc.|TECX - Operating profit EBITDA|Net earnings per share for the last 12 months Tectonic Therapeutic|TECX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months tectonictx.com|TECX - Net earnings per share growth this year|Projected earnings per share increase next year Tectonic Therapeutic, Inc.
- sales revenue and business income indicators:
Summary company analytics:Tectonic Therapeutic, Inc.
For Tectonic Therapeutic, Inc. (TECX), tracking actual cash flow from core operations is critical amidst fierce competition with pharma behemoths. This metric captures the actual cash flow from sales, stripped of non-cash charges, which allows for an assessment of the biotech's ability to sustain development without excessive reliance on costly loans based on the company's calculated EBITDA.
Who Tectonic Therapeutic, Inc. competes with
Company profit before taxes, interest and amortization HLN (Haleon plc)|KVUE: Operating profit before deduction of amortization|Verona Pharma - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharma - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization perrigo.com PRGO|Profit before payment of interest, taxes and amortization Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos N.V.)|Operating profit EBITDA ANI Pharmaceuticals Corp ANIP|Afrezza - Operating profit EBITDA|amphastar.com (AMPH) - Operating profit before deduction of amortization|PCRX: Operating profit EBITDA|SPRY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Theravance|Profit before interest, taxes and amortization Aquestive Corp AQST|Operating profit EBITDA SCPH|Tonix Pharmaceuticals Holding Corp. - Operating profit before amortization|China SXT Pharmaceuticals - Operating profit before deduction of amortization|EPRX: Operating profit before amortization|BHST: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Invizyne|Oramed Pharmaceuticals Inc. (ORMP) - Profit before payment of interest, taxes and amortization|ENTX (Entera Bio Ltd) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization HYFT|ABVC BioPharma, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CPIX|Operating income before deduction of amortization Quantum BioPharma Corp|Profit before payment of interest, taxes and amortization FibroGen FGEN|Operating profit EBITDA telomirpharma.com TELO|Rani Therapeutics Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization SNYR (synergychc.com)|Rallybio (RLYB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Lexaria Bioscience Corp|Operating profit before deduction of amortization PULM|PTHL - Operating profit before depreciation charges|Operating profit EBITDA APM|Operating income before deduction of amortization Lyra Therapeutics|Profit before payment of interest, taxes and amortization Impact BioMedical Inc IBO|TNFA - Operating profit before deduction of amortization|cbdMD, Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|LIPO: Company profit before taxes, interest and amortization|OPTN (Optinose) - Operating profit EBITDA|Operating profit before deduction of amortization Pieris (PIRS)|Profit before payment of interest, taxes and amortization Procaps Group S.A. (PROC)|Operating profit EBITDA petrospharma.com (PTPI)|Profit before payment of interest, taxes and amortization Qilian International Holding QLI|Income before deduction of interest, taxes and amortization SLRN|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
